ScreenCell® Technology
They trust us
ScreenCell® is a simple and rapid liquid biopsy method for isolating circulating tumor cells (CTCs) from a single blood sample in patients with solid tumors.
It is available in 7 single-use CTC isolation kits, each designed for specific downstream applications and supplied with tailored protocols.
Explore the full range of ScreenCell® CTC isolation kits, each specifically designed to meet the diverse needs of liquid biopsy applications.
Blood draw
< 4 hours
Fixed CTCs
on the isolation support
Blood draw
4 hours > 3 days
Fixed CTCs
on the isolation support
Blood draw
4 hours > 3 days
Fixed CTCs
in suspension
or
Fixed CTCs
on microscope slide
Blood draw
< 4 hours
Fixed CTCs
in suspension
or
Fixed CTCs
on microscope slide
Blood draw
< 4 hours
Viable CTCs
on the isolation support
Blood draw
4 hours > 3 days
Fixed CTCs
on the isolation support
Blood draw
< 4 hours
Viable CTCs
in suspension
Blood draw
< 4 hours
Viable CTCs
on the isolation support
Blood draw
< 4 hours
Viable CTCs
in suspension
Scientific validation
We are transforming circulating tumor cell research into concrete solutions to improve cancer patient care.
Learn more about the French company that manufactures CTC isolation kits.
Discover our latest news and company culture through our various articles.
Follow ScreenCell on LinkedIn
